ALNYLAM PHARMACEUTICALS, INC. Annual Income Tax Expense (Benefit) in USD from 2010 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
Alnylam Pharmaceuticals, Inc. quarterly/annual Income Tax Expense (Benefit) history and growth rate from 2010 to 2023.
  • Alnylam Pharmaceuticals, Inc. Income Tax Expense (Benefit) for the quarter ending September 30, 2024 was $2.91M, a 2.71% decline year-over-year.
  • Alnylam Pharmaceuticals, Inc. Income Tax Expense (Benefit) for the twelve months ending September 30, 2024 was $11.2M, a 59.1% increase year-over-year.
  • Alnylam Pharmaceuticals, Inc. annual Income Tax Expense (Benefit) for 2023 was $6.73M, a 61.5% increase from 2022.
  • Alnylam Pharmaceuticals, Inc. annual Income Tax Expense (Benefit) for 2022 was $4.16M, a 512% increase from 2021.
  • Alnylam Pharmaceuticals, Inc. annual Income Tax Expense (Benefit) for 2021 was $680K, a 74.6% decline from 2020.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Annual (USD)
Income Tax Expense (Benefit), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $6.73M +$2.56M +61.5% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-15
2022 $4.16M +$3.48M +512% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-15
2021 $680K -$2M -74.6% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-15
2020 $2.68M +$1.82M +211% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-23
2019 $863K +$40K +4.86% Jan 1, 2019 Dec 31, 2019 10-K 2022-02-10
2018 $823K +$823K Jan 1, 2018 Dec 31, 2018 10-K 2021-02-11
2017 $0 $0 Jan 1, 2017 Dec 31, 2017 10-K 2020-02-13
2016 $0 $0 Jan 1, 2016 Dec 31, 2016 10-K 2019-02-14
2015 $0 +$40.2M Jan 1, 2015 Dec 31, 2015 10-K 2016-02-12
2014 -$40.2M -$37.5M -1392% Jan 1, 2014 Dec 31, 2014 10-K 2016-02-12
2013 -$2.7M +$7.88M +74.5% Jan 1, 2013 Dec 31, 2013 10-K 2016-02-12
2012 -$10.6M -$10.6M Jan 1, 2012 Dec 31, 2012 10-K 2015-02-13
2011 $0 -$514K -100% Jan 1, 2011 Dec 31, 2011 10-K 2014-02-20
2010 $514K Jan 1, 2010 Dec 31, 2010 10-K 2013-02-19
* An asterisk sign (*) next to the value indicates that the value is likely invalid.